Document is current
Any future updates will be listed below
-
Authors
Wong, Carlos King Ho http://orcid.org/0000-0002-6895-6071
Lui, David Tak Wai http://orcid.org/0000-0002-9813-1126
Xiong, Xi http://orcid.org/0000-0002-9418-7448
Chui, Celine Sze Ling http://orcid.org/0000-0003-1513-8726
Lai, Francisco Tsz Tsun http://orcid.org/0000-0002-9121-1959
Li, Xue http://orcid.org/0000-0003-4836-7808
Wan, Eric Yuk Fai http://orcid.org/0000-0002-6275-1147
Cheung, Ching Lung http://orcid.org/0000-0002-6233-9144
Lee, Chi Ho http://orcid.org/0000-0002-7569-409X
Woo, Yu Cho
Au, Ivan Chi Ho http://orcid.org/0000-0001-5904-8322
Chung, Matthew Shing Hin http://orcid.org/0000-0002-1669-4479
Cheng, Franco Wing Tak http://orcid.org/0000-0001-7818-1575
Tan, Kathryn Choon Beng http://orcid.org/0000-0001-9037-0416
Wong, Ian Chi Kei http://orcid.org/0000-0001-8242-0014
-
Funding
Funding for this research was provided by:
Health and Medical Research Fund (COVID19F01)
- License Information
-
More Information
Article History
Received: 22 June 2022
Accepted: 1 September 2022
First Online: 14 October 2022
Declarations
:
: The study was approved by the Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong West Cluster (UW 21-149 and UW 21-138); and the Department of Health Ethics Committee (LM 21/2021). All data were anonymised, and the project was granted waiver of participant consent.
: Not applicable.
: Carlos King Ho Wong reports receipt of research funding from the EuroQoL Group Research Foundation, the Hong Kong Research Grants Council, and the Hong Kong Health and Medical Research Fund. Francisco Tsz Tsun Lai has been supported by the RGC Postdoctoral Fellowship under the Hong Kong Research Grants Council. Xue Li has received research grants from the Food and Health Bureau of the Government of the Hong Kong SAR, research and educational grants from Janssen and Pfizer; internal funding from University of Hong Kong; and consultancy fee from Merck Sharp & Dohme, unrelated to this work. Eric Yuk Fai Wan has received research grants from the Food and Health Bureau of the Government of the Hong Kong SAR and the Hong Kong Research Grants Council, outside the submitted work. Celine Sze Ling Chui has received grants from the Food and Health Bureau of the Hong Kong Government, Hong Kong Research Grant Council, Hong Kong Innovation and Technology Commission, Pfizer, IQVIA, and Amgen, and personal fee from Primevigilance Ltd., outside the submitted work. Esther Wai Yin Chan reports honorarium from Hospital Authority, grants from Research Grants Council (RGC, Hong Kong), grants from Research Fund Secretariat of the Food and Health Bureau, grants from National Natural Science Fund of China, grants from Wellcome Trust, grants from Bayer, grants from Bristol-Myers Squibb, grants from Pfizer, grants from Janssen, grants from Amgen, grants from Takeda, and grants from Narcotics Division of the Security Bureau of HKSAR, outside the submitted work. Ian Chi Kei Wong reports research funding outside the submitted work from Amgen, Bristol-Myers Squibb, Pfizer, Janssen, Bayer, GSK, Novartis, the Hong Kong RGC, and the Hong Kong Health and Medical Research Fund, National Institute for Health Research in England, European Commission, National Health and Medical Research Council in Australia, and also received speaker fees from Janssen and Medice in the previous 3 years, all outside the submitted work.
